Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Dutasteride and finasteride affect different cell types differently.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Lowering testosterone speeds up wound healing in male mice.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride may improve prostate cancer treatment outcomes.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

MC4R gene variants not linked to female hair loss.

Chromosomal differences affect how muscle cells respond to testosterone.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Excess androgens may cause PCOS, not just be a symptom.